OSCR Oscar Health, Inc.
Hospital & Medical Service Plans · NYSE · SEC CIK 1568651 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $5.14B | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B |
| SG&A expense | $721.89M | $691.08M | $706.23M | $511.03M | $521.59M | $534.49M | $482.76M | $465.82M |
| Operating income | $178.02M | $388.63M | $704.09M | -$333.75M | -$129.25M | -$230.48M | $297.12M | -$147.73M |
| Interest expense | $4.73M | $4.71M | $5.38M | -$1.10M | $6.86M | $5.85M | $5.99M | $6.03M |
| Pretax income | $175.38M | $383.01M | $698.77M | -$352.68M | -$139.29M | -$233.54M | $288.21M | -$153.69M |
| Income tax | $8.08M | $21.18M | $19.75M | -$247,000 | -$1.81M | -$5.04M | $12.71M | -$404,000 |
| Net income | $167.28M | $361.81M | $679.00M | -$352.61M | -$137.45M | -$228.36M | $275.27M | -$153.55M |
| EBITDA | $184.56M | $394.67M | $711.10M | -$325.87M | -$121.94M | -$223.51M | $303.85M | -$138.50M |
| EPS (basic) | 0.54 | 1.20 | 2.28 | — | -0.53 | -0.89 | 1.10 | — |
| EPS (diluted) | 0.49 | 1.10 | 2.07 | — | -0.53 | -0.89 | 0.92 | — |
| Weighted avg. shares (diluted) | 346.46M | 333.43M | 329.75M | — | 259.27M | 255.53M | 305.94M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $4.47B | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.55B |
| Short-term investments | $3.02B | $4.48B | $1.99B | $1.22B | $887.59M | $938.10M | $751.49M | $624.46M |
| Receivables | $303.30M | $380.06M | $587.02M | $362.68M | — | — | — | — |
| Current assets | $8.32B | $9.37B | $7.78B | $4.61B | $3.76B | $4.31B | $3.77B | $2.85B |
| PP&E, net | $109.31M | $101.49M | $94.19M | $88.35M | $83.42M | $77.67M | $72.00M | $66.79M |
| Total assets | $10.01B | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B |
| Current liabilities | $7.30B | $8.69B | $7.14B | $4.86B | $3.98B | $4.87B | $4.15B | $3.46B |
| Long-term debt | $432.41M | $431.63M | $430.88M | $430.10M | $686.29M | $299.94M | $299.75M | $299.56M |
| Total debt | $432.41M | $431.63M | $430.88M | $430.10M | $686.29M | $299.94M | $299.75M | $299.56M |
| Total liabilities | $7.78B | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B |
| Shareholders' equity | $2.22B | $2.05B | $1.66B | $977.65M | $1.02B | $1.16B | $1.33B | $1.01B |
| Net debt | -$4.03B | -$3.64B | -$4.37B | -$2.34B | -$1.46B | -$2.30B | -$1.94B | -$1.25B |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.20B | $2.09B | $2.62B | $671.90M | -$964.66M | $509.07M | $878.54M | $346.82M |
| Capital expenditure | $11.31M | $11.76M | $8.79M | $9.06M | $9.01M | $9.28M | $9.03M | $6.82M |
| Free cash flow | -$1.21B | $2.08B | $2.61B | $662.84M | -$973.66M | $499.79M | $869.52M | $340.00M |
| Investing cash flow | $1.58B | -$2.83B | -$590.25M | -$48.71M | $150.08M | -$168.21M | -$174.23M | -$31.45M |
| Financing cash flow | $10.85M | $13.29M | -$3.60M | $8.17M | $364.03M | $22.13M | $4.87M | $3.82M |
| Depreciation & amortization | $6.54M | $6.03M | $7.02M | $7.88M | $7.31M | $6.97M | $6.73M | $9.23M |
| Stock-based compensation | $22.29M | $20.65M | $15.97M | $18.09M | $20.48M | $24.11M | $24.98M | $25.86M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.